GGrantIndex
Sort

59,101 grants matching hypertension

Project 2: Menopause, Midlife and Cardiovascular Health in Early Old Age

$1,386,755
Rebecca C Thurston · University Of Pittsburgh At Pittsburgh · U19 · FY2020 · AG

Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)

$1,386,598
Stella Maria Hartinger · Universidad Peruana Cayetano Heredia · UH3 · FY2024 · HL

Measure development to accelerate the translation of evidence based clinical guidelines into practice

$1,386,475
Carolyn Anne Berry · New York University School Of Medicine · U01 · FY2020 · TR

Maternal and Infant Environmental Health Riskscape (MIEHR) Research Center

$1,385,910
Elaine Symanski · Baylor College Of Medicine · P50 · FY2024 · MD

Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer’s disease and its related dementias

$1,385,735
Hyacinth Idu Hyacinth · University Of Cincinnati · R01 · FY2022 · AG

Framingham Project/O'Donnell

$1,385,142
Christopher O'Donnell · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

The Family Blood Pressure Program (GENOA Network)

$1,384,170
Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · U01 · FY2006 · HL

Development of the Predictive NeuroCardiovascular Simulator

$1,383,997
Colleen E Clancy · University Of California At Davis · OT2 · FY2018 · OD

SCOR IN ISCHEMIC HEART DISEASE IN BLACKS

$1,383,918
Boston University Medical Campus · P50 · FY2002 · HL

PRECURSORS OF STROKE INCIDENCE AND PROGNOSIS

$1,383,143
Boston University Medical Campus · R01 · FY2003 · NS

National Sleep Research Resource (NSRR)

$1,382,575
Susan S Redline · Brigham And Women'S Hospital · R24 · FY2017 · HL

Leveraging Family Data to Identify Genetic Variants for Sleep Apnea

$1,382,562
Susan S Redline · Brigham And Women'S Hospital · R01 · FY2014 · HL

PDE7 Inhibitor for the Treatment of Cocaine Use Disorder

$1,382,131
George Gaitanaris · Omeros Corporation · U01 · FY2023 · DA

Animal MRI/Imaging Core

$1,382,047
Andrew Arai · National Heart, Lung, And Blood Institute · ZIC · FY2015 · HL

METABOLIC DETERMINANTS OF HYPERTENSION

$1,381,559
University Of Michigan At Ann Arbor · P01 · FY2002 · HL

Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC

$1,381,257
Gaylan L Rockswold · Hennepin Healthcare Research Institute · U01 · FY2021 · NS

Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy

$1,380,699
Tonia S Rex · Vanderbilt University Medical Center · U24 · FY2020 · EY

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

$1,380,310
Daniel Woo · University Of Cincinnati · U01 · FY2017 · NS

Reducing Breast Cancer Recurrence with Weight Loss: A Vanguard Trial

$1,379,539
Cheryl L Rock · University Of California, San Diego · R01 · FY2010 · CA

Implementing and Scaling Up a Team-based Care Strategy for Hypertension Control in Colombia and Jamaica

$1,378,550
Marshall Kerr Tulloch-Reid · University Of The West Indies · UH3 · FY2022 · HL

Environmental Genetics

$1,378,490
Shuk-Mei Ho · University Of Cincinnati · P30 · FY2006 · ES

Implementing and Scaling Up a Team-based Care Strategy for Hypertension Control in Colombia and Jamaica

$1,378,329
Marshall Kerr Tulloch-Reid · University Of The West Indies · UH3 · FY2023 · HL

Genetic Mediators of Metabolic Cardiovascular Disease Risk

$1,377,767
William E Kraus · Duke University · RC2 · FY2010 · HL

The VETSA Longitudinal Twin Study of Cognition and Aging

$1,377,704
Michael J. Lyons · Boston University (Charles River Campus) · R01 · FY2011 · AG

The spectrum of cognitive impairment including Alzheimer’s Disease and Related Dementias after liver transplantation

$1,377,684
Jennifer C. Lai · University Of California, San Francisco · R01 · FY2023 · AG